title: Paraoxonase protects against chlorpyrifos toxicity in mice.
abstract: Paraoxonase can hydrolyze paraoxon (PO), chlorpyrifos-oxon (CPO) and other organophosphates. Previous studies have indicated that the levels of serum paraoxonase can influence the toxicity of PO and CPO. In the present study we have investigated whether exogenous paraoxonase administered to mice would offer protection toward the acute toxicity of a phosphorothioate, chlorpyrifos (CPS). Paraoxonase was purified from rabbit serum and injected i.v., or i.v. plus i.p., in mice. Inhibition of acetylcholinesterase (AChE) in brain, diaphragm, plasma and red blood cells was measured as an index of CPS (100 mg/kg) toxicity. Administration of paraoxonase 30 min before CPS increased plasma enzyme activity toward CPO by 35-fold, and protected against its toxicity; protection was still present at 24 h, when enzyme activity was still 20-fold over basal. When paraoxonase was given 30 min after CPS, a significant protection against CPS toxicity was still observed, while after 3 h the protective effect was decreased. To mimic conditions of severe acute poisoning, a higher dose of CPS (150 mg/kg) was also administered. Administration of paraoxonase 30 min after this exposure abolished cholinergic signs and significantly protected against AChE inhibition. These results indicate that exogenous paraoxonase offers significant protection against CPS toxicity when administered both before and after the organophosphate, suggesting that it may be considered as a potential additional treatment of organophosphate poisoning.
authors.affiliation: Department of Environmental Health, XD-41, University of Washington, Seattle 98195, USA.
authors.forename: W F
authors.initials: WF
authors.lastname: Li
authors.forename: C E
authors.initials: CE
authors.lastname: Furlong
authors.forename: L G
authors.initials: LG
authors.lastname: Costa
mesh_terms: D000818:Animals; D043303:Aryldialkylphosphatase; D001921:Brain / Q000187:drug effects / Q000201:enzymology; D004390:Chlorpyrifos / Q000031:analogs & derivatives / Q000378:metabolism / Q000633:toxicity*; D002800:Cholinesterase Inhibitors / Q000633:toxicity*; D003964:Diaphragm / Q000187:drug effects / Q000201:enzymology; D004347:Drug Interactions; D004912:Erythrocytes / Q000187:drug effects / Q000201:enzymology; D004950:Esterases / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*; D005260:Female; D006868:Hydrolysis; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D051379:Mice; D008807:Mice, Inbred BALB C; D011817:Rabbits
chemical_list: D002800:Cholinesterase Inhibitors; C009618:O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate; D004950:Esterases; D043303:Aryldialkylphosphatase; D004390:Chlorpyrifos